Arcutis Biotherapeutics, Inc. financial statements, including revenue, expenses, profit, and loss

The total revenue of ARQT for the last quarter is 44.76 M USD, and it's 45.04% higher compared to the previous quarter. The net income of Q3 24 is -41.54 M USD.